Current Approaches in Drug Designing and Development

JCADD

ISSN Online:

Journal DOI:

Journals Menu

About Journal

Current Approaches in Drug Designing and Development (JCADD) is an interdisciplinary, peer reviewed open access journal that publishes the highest quality scientific articles amalgamating broad range of fields including molecular modelling, clinical research and drug discovery and delivery.

The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include pharmacokinetics, dosage analysis, or drug administration analysis.

Aim and Scope

JCADD journal focuses on the latest research in all related fields of drug targets, rational drug discovery, computer-aided drug design and the different types of drug design, development methods. Patient safety, clinical outcomes, programs for the development, safety, molecular modeling, ligand-based interaction, development of the generic drug, in silico chemoinformatics and bioinformatics technologies, receptor agonist/antagonist, protease substrate/inhibitor, peptidomimetic, quality by design, Design for reliability in drug development. bayesian sequential design for multi-regional design, design and analysis for target clinical trials, design and analysis for diagnostic procedures, Adaptive design for early clinical development, design for biosimilar studies, design for bioassay development and validation, design for statistical genetics, design for assessment of drug to drug interaction, design for bridging studies, design for stability analysis, etc.

JCADD journal welcomes authors to submit articles in any format like research, review opinions, new, short communication, mini review, perspective, commentary, etc. in the field of drug designing and development from any corner across globe.

Editorial Managing Policy

JCADD is using Editorial Manager Policy to attain quality in review process. This Policy follows an online manuscript submission, review and tracking systems. Review processing is performed by journal editorial board members or by outside experts. Editorial Managing Policy simplifies the publication process and helps the author to get track of their articles.

JCADD Open Access

As JCADD is an International Open Access journal, all the articles published under this journal will be accessible to all internet users throughout the world without any barrier of access under the terms of the Creative Commons Attribution License. All published articles will be assigned DOI provided by Cross Ref. JCADD will keep up-to- date with the latest advancements in the fields of Drug Designing.

Abstracts and Pdfs of all articles published are freely available to all interested online readers immediately after publication without any restrictions or any other subscriptions to researchers worldwide.

Authors are welcome to submit the manuscript through our online portal and or send us an E-mail attachment to our Editorial Office.

Journal Highlights

Cheminformatics
Clinical and Medicinal Chemistry
Combinatorial Library Design
Database Mining And Data Analysis
Docking
Drug Analytics
Drug Biochemistry
Drug Chemistry
Drug Designing
Drug Development
Drug Discovery
Drug Extraction Studies
Drug Safety Assessment
Homology Modeling
Immunology& Clinical Toxicology
Ligand Design
Ligand-Based Drug Design
Medicinal Chemistry
Molecular Docking
Molecular Mechanics
Quantum Mechanics
Molecular Modeling
Molecular Modification
Organic chemistry
Orphan Drug
Pharmaceutical Analysis
Pharmaceutical Chemistry
Pharmacology
Pharmacology and Clinical Pharmacy
Pharmacophore Modeling in Drug Design
Pre-Clinical Development
Product Development

Qsar
Rational Drug Design
Protein Modeling And Structural Genomics
Qm Simulations in Biomacromolecules
Retrometabolic Drug Design
Reverse Transcriptase inhibitors
Screening
Structure-Based Drug Design
Structure-Based Molecular Design
Target Prediction
Pharmacophores
Pharmacovigilance
Phases of Drug Development
Physiologically-based pharmacokinetic modelling
Posology
Preclinical Drug Development
Prodrug
Protease Substrate/Inhibitor
Protein modeling and Structural genomics
Psychopharmacology
Quantitative structure-activity Relationship (QSAR)
Receptor Agonist/ Antagonist
Screening and Drug Design
Simcyp Simulator
Structure-activity Relationships
Structure-Based Molecular Design
Synthetic Chemistry
Target prediction
Therapeutic Window
Translational Drug Development

Information Menu

Subscribe to Newsletter

Plagiarism Check

Olites undergoes plagiarism check through ithenticate

TRACK YOUR ARTICLE

Downloads

Collaborations

Submit Your Article

info@olitesonline.org

Tweets

Browse By Subjects

info@olitesonline.org

(302) 467-1490